Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
Bangkok Post - January 30, 2007
Apiradee Treerutkuarkul
"Most of these costly drugs are produced somewhere else, not in Thailand. Nobody knows if they produce these drugs cheaply in other countries and just import into Thailand for expensive and profitable sales," the minister said.
Dr Mongkol said he had issued compulsory licences for two drugs - Kaletra, an advanced anti-Aids drug, and Plavix, a blockbuster treatment for heart disease.
Thailand is the first developing country to invoke compulsory licensing under the World Trade Organisation's rules for a non-Aids related drug.
The WTO allows a government to declare a "national emergency" and licence the production or sale of a patented drug without the permission of the foreign patent owner.
The minister invoked article 51 of the 1992 Patent Law to import or produce a generic version of the two drugs. In November, the ministry invoked the same law to import and produce the anti-Aids drug Efavirenz.
The Pharmaceutical Research and Manufacturers Association last week released a statement disapproving of the ministry's move, saying that compulsory licensing would only force more companies to relinquish patents for heart and anti-Aids drugs and could lead to the isolation of Thailand from the global biotechnology investment community.
Kaletra is manufactured by Abbott Laboratories, and Plavix by Sanofi-Aventis and Bristol-Myers Squib.
Dr Mongkol insisted compulsory licensing was essential as Thailand was facing an increase in the number of HIV-positive people. About 108,000 of 500,000 people living with HIV/Aids depend on GPO-VIR, the budget version of the first-line anti-retroviral therapy produced by the Government Pharmaceutical Organisation (GPO).
An estimated 20,000 HIV-positive people have developed a resistance to the drug, and need the combination drugs of lopinavir and ritonavir, which is marketed as Kaletra.
The patented regimen cost 11,580 baht a month per patient and this could be cut to a third under compulsory licence, Dr Mongkol said.
In addition, over 200,000 Thais with heart disease problems currently take the drug clopidogrel, sold as Plavix, to reduce the risk of heart attack or stroke, and treat established peripheral artery disease and poor circulation in the legs that may cause pain during exercise, according to the National Health Security Office.
The patented version of the heart disease drug costs over 70 baht per tablet.
Thawat Sundarachan, head of the Disease Control Department, said the agency aimed to import the generic version of these two drugs from India and later ask the state-owned GPO to set up for local production.
This was expected to slash the price of Plavix by 90% to six baht per tablet.The ministry would issue a compulsory licence for Kaletra for a period of five years.
The compulsory licence for Plavix would run until the government could find another regimen to substitute for this heart disease medicine, he said.
Plavix inhibits platelets in the blood from clotting.
070130
BP070104
Copyright © 2007 - The Bangkok Post. Reproduction of this article (other than one copy for personal reference) must be cleared through the Bangkok Post.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .